New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 3, 2014
08:11 EDTCLDXCelldex to present CDX-014 preclinical proof of concept data at AACR
Celldex Therapeutics announced that data from preclinical studies evaluating the anti-tumor activity of the antibody-drug conjugate CDX-014 will be presented at the American Association of Cancer Research, or AACR, Annual Meeting 2014 in San Diego, California, April 5-9. CDX-014 targets the protein TIM-1, which is upregulated in several cancers, including renal and ovarian carcinomas.
News For CLDX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 15, 2014
16:03 EDTCLDXCelldex completes enrollment in Phase 3 ACT IV study
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use